Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Five Stocks To Buy: Eternal, Trent, Eicher Motors And More | June 22, 2026
Top picks for Monday, June 22, include food-delivery platform Eternal, retail major Trent, automotive heavyweight Eicher Motors, PSU lender Union Bank of India, and pharmaceutical player Mankind Pharma.
Bernstein backs Zydus, Lupin and Sun Pharma on innovation shift
Nandan Kulkarni, Director–India Healthcare & Senior Research Analyst at Bernstein, sees strong opportunities in CDMOs, specialty therapies, biosimilars and licensing deals. While favouring Zydus, Lupin and Sun Pharma, he remains cautious on Biocon and Mankind Pharma, and argues that India's shift from generics to innovation could drive the next phase of growth for the pharma industry.
Ipca Laboratories among 5 stocks showing bullish RSI upswing
Five Nifty500 stocks, including Leela Palaces, Eris Lifesciences, Indian Bank, Mankind Pharma, and Ipca Laboratories, showed bullish momentum as their RSI crossed above 50, signaling potential upward price movement.
Stock Picks Today: Adani Ports, Hindalco, JSW Steel, Mankind Pharma, LTIM And More On Brokerages' Radar
Check out top stocks under brokerages' radar heading into trade today.
Mankind Pharma Ltd eases for fifth straight session
Mankind Pharma Ltd is quoting at Rs 2412.2, down 0.47% on the day as on 13:19 IST on the NSE. The stock tumbled 2.88% in last one year as compared to a 3.49% slide in NIFTY and a 15.46% spurt in the Nifty Pharma index.
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?
Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pharma index rebounded from early losses to rise nearly 1%, crossing the 25,000 mark and hitting a fresh 52-week high of 25,043.
Stocks to Watch Today: Hindalco, AB Capital, ASK Automotive, Dredging Corp, PTC India, Mankind Pharma,... - Moneycontrol.com
Stocks to Watch Today: Hindalco, AB Capital, ASK Automotive, Dredging Corp, PTC India, Mankind Pharma,...Moneycontrol.com
Mankind Pharma profit jumps 30% on chronic therapy demand in Q4
Mankind Pharma announced a significant 30 percent profit increase for the fourth quarter. This growth was fueled by strong demand for chronic therapies and consumer healthcare products. The company's domestic formulations business is showing a revival. Improved sales execution and the successful integration of Bharat Serums and Vaccines contributed to this positive performance.
Mankind Pharma Q4 revenue rises 12%; chronic therapies drive margin expansion
Mankind Pharma reported strong fourth-quarter operating performance driven by healthy domestic demand, chronic therapy growth and improved margins, while international business growth remained muted amid geopolitical challenges.
Stocks to Watch for May 20: BPCL, Mankind Pharma, Orkla India, PI Industries and more
BPCL profit slumps on exceptional loss, while Orkla India, Godawari Power and Karnataka Bank report strong earnings growth. PTC India’s profit declines sharply, and JSW Energy moves to raise its stake in Toshiba JSW. Here are the stocks to watch ahead of Wednesday’s trading session.
Mankind Pharma Ltd rises for third straight session
Mankind Pharma Ltd is quoting at Rs 2511.4, up 2% on the day as on 12:49 IST on the NSE. The stock is down 2.38% in last one year as compared to a 4.94% slide in NIFTY and a 13.93% slide in the Nifty Pharma index.
Mankind Pharma Ltd up for fifth session
Mankind Pharma Ltd is quoting at Rs 2439.2, up 2.69% on the day as on 12:44 IST on the NSE. The stock is up 1.29% in last one year as compared to a 0.65% spurt in NIFTY and a 14.52% spurt in the Nifty Pharma.